Please ensure Javascript is enabled for purposes of website accessibility

Fresenius Medical (FMS)

This European pharmaceutical company is growing at a double-digit pace, with two analysts raising their 2016 EPS estimates in the past 30 days.

Fresenius Medical (FMS)
From DRIP Investor

While much of the health-care sector has been under pressure, medical device and technology companies have been outperforming the group. A number of factors are driving share prices:

• There has been takeover activity in the group. The latest big deal is Abbott Laboratories (ABT) announcing a deal to acquire St. Jude Medical (STJ), a maker of cardiovascular devices.

• The tax burden on medical device makers has been reduced, at least temporarily. At the end of 2015, President Obama signed into law an omnibus tax and spending bill that pauses the medical device tax for two years.

• Earnings in the latest quarter were better than expected for many med tech companies. 3M (MMM), Baxter International (BAX), Becton Dickinson (BDX), C.R. Bard (BCR), General Electric (GE), and Zimmer Biomet (ZBH) were some of the medical-device companies that beat the consensus earnings estimate in the most recent quarter.

Germany-based Fresenius Medical (FMS) makes dialysis systems, and its American Depositary Receipts (ADRs) trade on U.S. exchanges. FMS is one of my favorites

Charles A. Carlson, CFA, DRIP Investor,, 800-233- 5922, June 2016